Wfs1 mutation makes mice sensitive to insulin-like effect of acute valproic acid and resistant to streptozocin

Terasmaa, Anton; Oflijan, Julia; Punapart, Marite; Must, Anne; Kõks, Sulev; Vasar, Eero; Soomets, Ursel; Hansen, Mats; Ehrlich, Kersti.
J. physiol. biochem ; 67(3): 381-390, sept. 2011.
Artículo en Inglés | IBECS (España) | ID: ibc-122603

Documentos relacionados

  1. Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: a protein binding model.
  2. Predictive ability of published population pharmacokinetic models of valproic acid in Thai manic patients.
  3. Therapeutic drug monitoring of valproic acid.
  4. Influence of CYP2C9 and CYP2A6 on plasma concentrations of valproic acid: a meta-analysis.
  5. Valproate, divalproex, valpromide: Are the differences in indications justified?
  6. Population pharmacokinetics of valproic acid in adult Chinese patients with bipolar disorder.
  7. Pharmacokinetic variability of valproate in women of childbearing age.
  8. Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.
  9. O<sup>6</sup>-methylguanine DNA methyltransferase and glucose transporter 2 in foregut and hindgut gastrointestinal neuroendocrine neoplasms.
  10. Metabolic effects of B-glucans (Saccharomyces cerevisae) per os administration in rats with streptozotocin-induced diabetes